ChartMillOctober 28, 2026 at 8:26 AM NY2 Hours Ago
Boston Scientific (NYSE:BSX) Q3 2026 Results In Line, Stock Slips Premarket
Boston Scientific Q3 2026 sales rise 1.5% to $5.138B; adjusted EPS $0.73, in line with consensus, while shares fall 4.1% premarket.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: ChartMill
